Premium
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma
Author(s) -
Lee Hun J.,
Schmelz Jacob L.,
Cramer Fred,
Romaguera Jorge E.,
Badillo Maria,
Wang Michael
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16378
Subject(s) - ibrutinib , carfilzomib , bortezomib , mantle cell lymphoma , proteasome inhibitor , medicine , bruton's tyrosine kinase , cancer research , oncology , pharmacology , lymphoma , tyrosine kinase , multiple myeloma , leukemia , chronic lymphocytic leukemia , receptor